The European baseline series and recommended additions: 2023.

Europe allergen baseline series hapten patch test recommended addition

Journal

Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950

Informations de publication

Date de publication:
Feb 2023
Historique:
revised: 09 11 2022
received: 05 09 2022
accepted: 23 11 2022
pubmed: 29 11 2022
medline: 14 1 2023
entrez: 28 11 2022
Statut: ppublish

Résumé

The European baseline series was last updated in 2019. This article discusses the reasoning behind a further iteration of the series for 2023.

Identifiants

pubmed: 36443008
doi: 10.1111/cod.14255
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-92

Subventions

Organisme : European Academy of Dermato-venereology

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Wilkinson M, Gonçalo M, Aerts O, et al. The European baseline series and recommended additions: 2019. Contact Dermatitis. 2019;80(1):1-4.
Wilkinson SM, Badulici S, Giménez-Arnau A, et al. The European baseline series: criteria for allergen inclusion (with reference to formaldehyde releasers). Contact Dermatitis. 2021;85(2):125-128.
Uter W, Bauer A, Belloni Fortina A, et al. Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018. Contact Dermatitis. 2021;84(2):109-120.
Uter W, Wilkinson SM, Aerts O, et al. Patch test results with the European Baseline Series, 2019/20 - Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC. Contact Dermatitis. 2022;87:343-355. doi:10.1111/cod.14170
Uter W, Wilkinson SM, Aerts O, et al. European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20 - joint results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC. Contact Dermatitis. 2022;86(5):379-389.
Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, et al. Should methyldibromo glutaronitrile continue to be used in the European baseline series? A REIDAC national cross-sectional study. Contact Dermatitis. 2021;85(5):572-577.
Accessed February 2021. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32020R1682&from=EN.
Isaksson M, Lindberg M, Sundberg K, Hallander A, Bruze M. The development and course of patch test reactions to 2-hydroxyethyl methacrylate and ethyleneglycol dimethacrylate. Contact Dermatitis. 2005;53(5):292-297.
Uter W, Worm M, Brans R, et al. Patch test results with caine mix III and its three constituents in consecutive patients of the IVDK. Contact Dermatitis. 2021;84(6):481-483.
Geier J, Schubert S, Schnuch A, et al. A negative breakdown test in a fragrance mix I-positive patient does not rule out contact allergy to its fragrance constituents. Contact Dermatitis. 2021;84(6):407-418.
Mann J, McFadden JP, White JM, et al. Baseline series fragrance markers fail to predict contact allergy. Contact Dermatitis. 2014;70(5):276-281.
Frosch PJ, Pirker C, Rastogi SC, et al. Patch testing with a new fragrance mix detects additional patients sensitive to perfumes and missed by the current fragrance mix. Contact Dermatitis. 2005;52(4):207-215.
Goossens A, Aerts O. Contact allergy to and allergic contact dermatitis from formaldehyde and formaldehyde releasers: a clinical review and update. Contact Dermatitis. 2022;87(1):20-27.
Pontén A, Goossens A, Bruze M. Recommendation to include formaldehyde 2.0% aqua in the European baseline patch test series. Contact Dermatitis. 2013;69(6):372-374.
Whitehouse H, Uter W, Geier J, et al. Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers - results of the ESSCA network, 2015-2018. Contact Dermatitis. 2021;84(2):95-102.
Accessed March 26, 2021. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2019.137.01.0029.01.ENG&toc=OJ:L:2019:137:FULL.
Dendooven E, Darrigade AS, Foubert K, et al. The presence of sulfites in ‘natural rubber latex’ and ‘synthetic’ rubber gloves: an experimental pilot study. Br J Dermatol. 2020;182(4):1054-1055.
Grosch E, Mahler V. Allergic contact dermatitis caused by a catheter system containing sodium metabisulfite. Contact Dermatitis. 2017;76(3):186-187.
Febriana SA, Jungbauer F, Soebono H, Coenraads PJ. Occupational allergic contact dermatitis and patch test results of leather workers at two Indonesian tanneries. Contact Dermatitis. 2012;67(5):277-283.
Uter W, Aalto-Korte K, Agner T, et al. The epidemic of methylisothiazolinone contact allergy in Europe: follow-up on changing exposures. J Eur Acad Dermatol Venereol. 2020;34(2):333-339.
King N, Latheef F. Wilkinson SM trends in preservative allergy: benzisothiazolinone emerges from the pack. Contact Dermatitis. 2021;85(6):637-642.
Sasseville D. Alkyl glucosides: 2017 “allergen of the year”. Dermatitis. 2017;28(4):296.
Severin RK, Belsito DV. Patch testing with decyl and lauryl glucoside: how well does one screen for contact allergic reactions to the other? Dermatitis. 2017;28(6):342-345.
Bhoyrul B, Solman L, Kirk S, Orton D, Wilkinson M. Patch testing with alkyl glucosides: concomitant reactions are common but not ubiquitous. Contact Dermatitis. 2019;80(5):286-290.
Horton E, Uter W, Geier J, et al. Developing a cosmetic series: results from the ESSCA network, 2009-2018. Contact Dermatitis. 2021;84(2):82-94.
Bauer A, Geier J, Schreiber S, Schubert S, IVDK. Contact sensitization to plants of the Compositae family: data of the information network of departments of dermatology (IVDK) from 2007 to 2016. Contact Dermatitis. 2019;80(4):222-227.
Paulsen E, Andersen KE. Screening for Compositae contact sensitization with sesquiterpene lactones and Compositae mix 2.5% pet. Contact Dermatitis. 2019;81(5):368-373.
de Groot A. Linalool hydroperoxides. Dermatitis. 2019;30(4):243-246.
de Groot A. Limonene hydroperoxides. Dermatitis. 2019;30(6):331-335.
Ogueta IA, Brared Christensson J, Giménez-Arnau E, et al. Limonene and linalool hydroperoxides review: pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12.
Natsch A, Nägelin M, Leijs H, et al. Exposure source for skin sensitizing hydroperoxides of limonene and linalool remains elusive: an analytical market surveillance. Food Chem Toxicol. 2019;127:156-162.
Bennike NH, Palangi L, Christensson JB, et al. Allergic contact dermatitis caused by hydroperoxides of limonene and dose-response relationship-a repeated open application test (ROAT) study. Contact Dermatitis. 2019;80(4):208-216.
de Groot A, Gilissen L, Geier J, Orton D, Goossens A. Adding sorbitan sesquioleate to the European baseline series: necessary, reasonable, or unavoidable? Contact Dermatitis. 2019;81(3):221-225.
Stingeni L, Tramontana M, Bianchi L, et al. Patch test with sorbitan sesquioleate in Italian consecutive patients: a 1-year multicenter SIDAPA study. Contact Dermatitis. 2019;81(6):454-456.
Bennike NH, Johansen JD. Sorbitan sesquioleate: a rare cause of contact allergy in consecutively patch tested dermatitis patients. Contact Dermatitis. 2016;74(4):242-245.

Auteurs

S Mark Wilkinson (SM)

Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Margarida Gonçalo (M)

Clinic of Dermatology, University Hospital and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Olivier Aerts (O)

University Hospital Antwerp (UZA) and University of Antwerp (UA), Antwerp, Belgium.

Sonia Badulici (S)

Alfa Medical Services, Bucharest, Romania.
Dermato-Aesthetic Institute Dr. Irinel Nedelcu, Bucharest, Romania.

Heinrich Dickel (H)

Department of Dermatology, Venereology and Allergology, St. Josef Hospital, University Medical Centre, Ruhr University Bochum, Bochum, Germany.

Rosella Gallo (R)

Clinica Dermatologica-DISSAL-Università di Genova Ospedale Policlinico San Martino, Genova, Italy.

Jose L Garcia-Abujeta (JL)

Allergy Section, Marina Baixa Hospital, Villajoyosa, Spain.

Ana M Giménez-Arnau (AM)

Department of Dermatology, Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, Spain.

Curt Hamman (C)

Contact Dermatitis Institute, Phoenix, Arizona, USA.

Marcos Hervella (M)

Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain.

Marléne Isaksson (M)

Department of Occupational and Environmental Dermatology, Lund University, Skane University Hospital, Malmö, Sweden.

Jeanne D Johansen (JD)

National Allergy Research Centre, Department of Dermatology and Allergy, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark.

Vera Mahler (V)

Paul-Ehrlich-Institut, Langen, Germany.

Bo Niklasson (B)

Chemotechnique Diagnostics, Vellinge, Sweden.

Paolo Pigatto (P)

IRCCS Galeazzi Orthopaedic Institute, Milan Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Gyorgyi Ponyai (G)

Department of Dermatology-Venerology and Dermato-oncology, Semmelweis University, Budapest, Hungary.

Thomas Rustemeyer (T)

VU University, Amsterdam, Netherlands.

Marie L A Schuttelaar (MLA)

University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Radoslaw Spiewak (R)

Jagiellonian University Medical College, Krakow, Poland.

Luca Stingeni (L)

Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Jacob P Thyssen (JP)

Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.

Wolfgang Uter (W)

Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen-Nürnberg, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH